---
title: "GRIPM invests in the establishment of a new company in Shandong"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248721149.md"
description: "The Qichacha APP shows that GRIPM Additive Technology Co., Ltd. has been established with a registered capital of 50 million yuan. The business scope includes: sales of non-ferrous metal alloys; sales of high-performance non-ferrous metals and alloy materials; sales of forgings and powder metallurgy products, etc. Qichacha's equity penetration shows that the company is wholly owned by GRIPM under GRIPM Additive Technology Co., Ltd"
datetime: "2025-07-16T05:40:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248721149.md)
  - [en](https://longbridge.com/en/news/248721149.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248721149.md)
generator: "portal-rs"
---

# GRIPM invests in the establishment of a new company in Shandong

According to the Qichacha APP, GRIPM Technology Co., Ltd. has been established with a registered capital of 50 million yuan. Its business scope includes: sales of non-ferrous metal alloys; sales of high-performance non-ferrous metals and alloy materials; sales of forgings and powder metallurgy products, etc. Qichacha's equity penetration shows that the company is wholly owned by GRIPM under GRIPM Technology Co., Ltd

### Related Stocks

- [688456.CN](https://longbridge.com/en/quote/688456.CN.md)

## Related News & Research

- [METALS-Copper hovers below record high as non-US supply tightness remains in focus](https://longbridge.com/en/news/298394789.md)
- [Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2](https://longbridge.com/en/news/298452346.md)
- [MSCL: Phase II data for forazapadin in DMD and FSHD expected soon, with early signs of clinical benefit](https://longbridge.com/en/news/298504117.md)
- [Indonesian tycoon Haji Isam bids for stake in miner Bayan, Bloomberg News reports](https://longbridge.com/en/news/298410137.md)
- [EIQ: FDA setback delays heart failure solution, but strong finances and U.S. growth continue](https://longbridge.com/en/news/298376891.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**